Engineers Gate Manager LP Has $18.70 Million Stock Holdings in Cardinal Health, Inc. $CAH

Engineers Gate Manager LP increased its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 59.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 90,979 shares of the company’s stock after acquiring an additional 33,743 shares during the period. Engineers Gate Manager LP’s holdings in Cardinal Health were worth $18,696,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently bought and sold shares of the company. Norges Bank acquired a new stake in shares of Cardinal Health during the 4th quarter valued at about $790,344,000. Wellington Management Group LLP raised its position in Cardinal Health by 153.2% during the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock valued at $911,010,000 after acquiring an additional 3,511,579 shares in the last quarter. Holocene Advisors LP lifted its stake in Cardinal Health by 141.4% in the third quarter. Holocene Advisors LP now owns 1,926,170 shares of the company’s stock valued at $302,332,000 after acquiring an additional 1,128,358 shares during the last quarter. Marshall Wace LLP lifted its stake in Cardinal Health by 1,328.1% in the fourth quarter. Marshall Wace LLP now owns 951,259 shares of the company’s stock valued at $195,484,000 after acquiring an additional 884,648 shares during the last quarter. Finally, Barclays PLC grew its position in Cardinal Health by 109.3% in the third quarter. Barclays PLC now owns 1,584,214 shares of the company’s stock worth $248,658,000 after acquiring an additional 827,446 shares in the last quarter. 87.17% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms recently issued reports on CAH. Weiss Ratings lowered shares of Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research note on Tuesday, May 19th. Wells Fargo & Company reduced their price target on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Morgan Stanley upped their price target on Cardinal Health from $245.00 to $255.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 28th. Zacks Research lowered Cardinal Health from a “strong-buy” rating to a “hold” rating in a report on Friday, June 12th. Finally, Wall Street Zen lowered Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Monday. Fourteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, Cardinal Health currently has an average rating of “Moderate Buy” and a consensus price target of $246.93.

Cardinal Health Stock Down 0.6%

Shares of CAH opened at $226.29 on Thursday. The stock’s 50-day moving average price is $204.01 and its 200 day moving average price is $209.11. The firm has a market capitalization of $53.00 billion, a price-to-earnings ratio of 34.60, a P/E/G ratio of 1.25 and a beta of 0.52. Cardinal Health, Inc. has a 12-month low of $137.75 and a 12-month high of $233.60.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Thursday, April 30th. The company reported $3.17 EPS for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. The company had revenue of $60.94 billion during the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The firm’s revenue for the quarter was up 11.0% compared to the same quarter last year. During the same period last year, the firm earned $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Equities research analysts expect that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be given a dividend of $0.5158 per share. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date is Wednesday, July 1st. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.9%. Cardinal Health’s dividend payout ratio is 31.19%.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.